Epithelial-Mesenchymal Transition in Docetaxel-Resistant Prostate Cancer

Epithelial-Mesenchymal Transition in Docetaxel-Resistant Prostate Cancer

Castration-resistant prostate cancer (CRPCa) is an advanced stage of prostate cancer in which a tumour progresses even under androgen deprivation. Treatment alternatives for CRPCa remain very limited and mostly rely on docetaxel-based chemotherapy. Despite being shown to increase patients’ overall s...

Full description

Bibliographic Details
Main Author:	Camila Libardi do Amaral
Format:	Article
Language:	English
Published:	European Medical Journal 2017-06-01
Series:	European Medical Journal
Subjects:	castration-resistant prostate cancer (crpca) epithelial-mesenchymal transition (emt) docetaxel chemoresistance
Online Access:	https://www.emjreviews.com/urology/article/epithelial-mesenchymal-transition-in-docetaxel-resistant-prostate-cancer/

Similar Items

Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer
by: Natalia Jiménez, et al.
Published: (2020-11-01)

Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside
by: Samantha Gogola, et al.
Published: (2023-04-01)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
by: Milad Ashrafizadeh, et al.
Published: (2020-06-01)

Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies
by: Aviv Philip Goncharov, et al.
Published: (2024-02-01)

Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma—A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis
by: Veronika Skarkova, et al.
Published: (2019-03-01)

Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
by: Erika Di Zazzo, et al.
Published: (2019-09-01)

Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target
by: Enrique A. Castellón, et al.
Published: (2022-11-01)

An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?
by: Federico Armando, et al.
Published: (2022-12-01)

A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer
by: Sang Eun Yoon, et al.
Published: (2019-05-01)

The Significance of Cancer Stem Cells and Epithelial–Mesenchymal Transition in Metastasis and Anti-Cancer Therapy
by: Lili Liang, et al.
Published: (2023-01-01)

Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies
by: Sara Lovisa, et al.
Published: (2021-09-01)

Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
by: Wenrong Mu, et al.
Published: (2023-11-01)

FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer
by: Astrid Børretzen, et al.
Published: (2019-10-01)

Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
by: Marina Montagnani Marelli, et al.
Published: (2023-03-01)

Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma
by: Anastasios Goulioumis, et al.
Published: (2022-09-01)

Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
by: Victor Omoboyede, et al.
Published: (2023-04-01)

Editorial: Molecular mechanisms of epithelial-mesenchymal transition in cancer metastasis
by: Amr Amin, et al.
Published: (2022-12-01)

Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition
by: Wook Jin
Published: (2020-01-01)

Inhibition or Reversal of the Epithelial-Mesenchymal Transition in Gastric Cancer: Pharmacological Approaches
by: Joanna Kozak, et al.
Published: (2020-12-01)

BMAL1 Knockdown Leans Epithelial–Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells
by: Yuan Zhang, et al.
Published: (2021-05-01)

Efficacy and Prognostic Factors of Docetaxel Rechallenge on Metastatic Castration-resistant Prostate Cancer Patients
by: DUAN Liqun, et al.
Published: (2019-09-01)

The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition
by: Ayalur Raghu Subbalakshmi, et al.
Published: (2023-03-01)

Epithelial-Mesenchymal Transition in tumor microenvironment
by: Jing Yingying, et al.
Published: (2011-08-01)

Time to Castration Resistance as a Predictor of Response to Docetaxel in Metastatic Castration Resistance in Prostate Cancer
by: İlkay Gültürk, et al.
Published: (2022-11-01)

New Insights into the Role of Epithelial–Mesenchymal Transition during Aging
by: Francisco Santos, et al.
Published: (2019-02-01)

A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer
by: Dechao Feng, et al.
Published: (2022-01-01)

MLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer [Retraction]
by: Zhang T, et al.
Published: (2023-12-01)

Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study
by: María José Juan Fita, et al.
Published: (2023-10-01)

Endothelial Cells Promote Docetaxel Resistance of Prostate Cancer Cells by Inducing ERG Expression and Activating Akt/mTOR Signaling Pathway
by: Wenhao Zhou, et al.
Published: (2020-12-01)

Determine of the optimal number of cycles of docetaxel in the treatment of metastatic castration-resistant prostate cancer
by: Yuan-Chi Shen, et al.
Published: (2016-09-01)

Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
by: Ivonne Loeffler, et al.
Published: (2015-10-01)

Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
by: Thomas Wirth, et al.
Published: (2010-12-01)

Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer
by: Tuan Luu
Published: (2021-04-01)

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
by: Kaibo Guo, et al.
Published: (2021-04-01)

Quantifying the Epithelial-to-Mesenchymal Transition (EMT) from Bench to Bedside
by: Meredith S. Brown, et al.
Published: (2022-02-01)

Mechanochemical Signaling of the Extracellular Matrix in Epithelial-Mesenchymal Transition
by: Lewis E. Scott, et al.
Published: (2019-07-01)

Overexpression of REST Represses the Epithelial–Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells
by: Sebastián Indo, et al.
Published: (2024-03-01)

Ultraviolet B-induced Otx2 expression in lens epithelial cells promotes epithelial–mesenchymal transition
by: Yasuo Yoshitomi, et al.
Published: (2019-02-01)

Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
by: Mehrdad Hashemi, et al.
Published: (2023-04-01)

The role of the endothelin axis in promoting epithelial to mesenchymal transition and lymph node metastasis in prostate adenocarcinoma
by: Sophia Papanikolaou, et al.
Published: (2017-01-01)